- Report
- January 2025
- 240 Pages
Global
From €4238EUR$4,799USD£3,620GBP
- Report
- January 2025
- 153 Pages
Global
From €5255EUR$5,950USD£4,489GBP
- Report
- May 2025
- 182 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- June 2025
- 264 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- May 2025
- 141 Pages
Global
From €2649EUR$2,999USD£2,263GBP
- Report
- June 2025
- 400 Pages
Global
From €4371EUR$4,949USD£3,734GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2650EUR$3,000USD£2,263GBP
- Report
- December 2024
- 182 Pages
Global
From €3378EUR$3,825USD£2,886GBP
€3974EUR$4,500USD£3,395GBP
- Report
- March 2025
- 228 Pages
Global
From €2208EUR$2,500USD£1,886GBP
- Drug Pipelines
- May 2025
- 100 Pages
Global
From €2463EUR$2,789USD£2,104GBP
- Report
- July 2024
- 316 Pages
Global
From €4372EUR$4,950USD£3,734GBP
- Report
- May 2025
- 199 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 185 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 192 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 188 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 181 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- May 2025
- 189 Pages
Global
From €3131EUR$3,545USD£2,675GBP
€3479EUR$3,939USD£2,972GBP
- Report
- April 2025
- 175 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- April 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- April 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,387GBP

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat.
The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more